Pueblo Grande Museum ‐ Partial Library Catalog ‐ Sorted by Title Book Title Author Additional Author Publisher D
![Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors | Journal of Medicinal Chemistry Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm301024w/asset/images/medium/jm-2012-01024w_0007.gif)
Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors | Journal of Medicinal Chemistry
Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells | Journal of Medicinal Chemistry
![Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells | Journal of Medicinal Chemistry Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c01246/asset/images/large/jm2c01246_0005.jpeg)
Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells | Journal of Medicinal Chemistry
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy) | Journal for ImmunoTherapy of Cancer
![Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors | Journal of Medicinal Chemistry Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm301024w/asset/images/large/jm-2012-01024w_0002.jpeg)
Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors | Journal of Medicinal Chemistry
![Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells | Journal of Medicinal Chemistry Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c01246/asset/images/large/jm2c01246_0002.jpeg)